NH TherAguix is a French biotech start-up developing innovative nanomedicine that improve radiation therapy benefits without modifying current clinical workflows.
Our leading product, AGuIX® is a nanoparticle designed to improve the localization of solid tumors and the outcomes of radiation therapy by a unique intravenous injection.
The company is pursuing its strategy ambitiously, with 5 Phase 2 trials recruiting in Europe and USA.
Drug Product Manager / Responsable produit fini
Head accountant / Responsable Finance et Support Business